Steve Blum Joins iO Urology’s Board of Directors

iO Urology has added Steve Blum to its Board of Directors. He brings to the governing body a wealth of experience and a track record of success in urological medical devices. 
 
Blum’s recent roles included global president at both Coloplast and American Medical Systems. Over his six-year tenure at Coloplast, Blum was instrumental in leading the company’s Men’s Health, Endosurgery, and Women’s Health Interventional Urology divisions. Under his leadership, Coloplast achieved significant global growth and operational excellence.
 
Before being hired at Coloplast, Blum was global president and general manager of the FPH Division at American Medical Systems, where he managed operations in 75 countries. His leadership was pivotal in positioning American Medical Systems as a leader in developing and marketing medical devices that restore pelvic health for both men and women.
 
Blum’s appointment to the iO Urology Board is a testament to his strong strategic mindset, growth orientation, and commitment to excellence, according to company executives. 
 
iO Urology is dedicated to advancing patient outcomes by offering a convenient, accessible solution for managing urological conditions in the home. Using embedded cellular connectivity, the CarePath device provides reliable, accurate data that improves the diagnosis and management of lower urinary tract symptoms. Knoxville, Tenn.-based iO Urology develops and delivers solutions that address the complexities of urological conditions, enhancing both patient quality of life and clinical effectiveness.